The Journal of Heart and Lung Transplantation
Volume 29, Issue 9 , Pages 981-988 , September 2010

Early adverse events as predictors of 1-year mortality during mechanical circulatory support

Portions of these analyses were presented at the Twenty-eighth Annual Meeting and Scientific Sessions of the International Society for Heart & Lung Transplantation, Boston, Massachusetts, April 9–12, 2008.

  • Elizabeth A. Genovese, MS

      Affiliations

    • Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    • ,
  • Mary Amanda Dew, PhD

      Affiliations

    • Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    • Department of Epidemiology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Department of Biostatistics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
    • Corresponding Author InformationReprint requests: Mary Amanda Dew, PhD, University of Pittsburgh School of Medicine and Medical Center, 3811 O'Hara St, Pittsburgh, PA 15213. Telephone: 412-624-3373. Fax: 412-383-4846
    • ,
  • Jeffrey J. Teuteberg, MD

      Affiliations

    • Cardiovascular Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Marc A. Simon, MD, MS

      Affiliations

    • Cardiovascular Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Jay K. Bhama, MD

      Affiliations

    • Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    • Heart, Lung, Esophageal Surgery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Christian A. Bermudez, MD

      Affiliations

    • Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    • Heart, Lung, Esophageal Surgery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania
    • ,
  • Kathleen L. Lockard, RN

      Affiliations

    • Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    • ,
  • Steve Winowich, MS

      Affiliations

    • Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    • ,
  • Robert L. Kormos, MD

      Affiliations

    • Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    • Heart, Lung, Esophageal Surgery Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

References 

  1. Goldstein DJ, Oz MC, Rose EA. Implantable left ventricular assist devices. N Engl J Med. 1998;339:1522–1533
  2. Frazier OH, Rose EA, Oz MC, et al. Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg. 2001;122:1186–1195
  3. Miller LW, Pagani FD, Russell SD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–896
  4. John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg. 2008;86:1227–1234discussion 34–5
  5. Lahpor J, Khaghani A, Hetzer R, et al. European results with a continuous-flow ventricular assist device for advanced heart-failure patients. Eur J Cardiothorac Surg. 2010;37:357–361
  6. Chen JM, Spanier TB, Gonzalez JJ, et al. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance. J Heart Lung Transplant. 1999;18:351–357
  7. Simon MA, Kormos RL, Murali S, et al. Myocardial recovery using ventricular assist devices: prevalence, clinical characteristics, and outcomes. Circulation. 2005;112:I32–I36
  8. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med. 2001;345:1435–1443
  9. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg. 2005;129:9–17
  10. Stevenson LW, Miller LW, Desvigne-Nickens P, et al. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure). Circulation. 2004;110:975–981
  11. Rogers JG, Butler J, Lansman SL, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol. 2007;50:741–747
  12. Slaughter MS, Rogers JG, Milano CA, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;
  13. Deng MC, Loebe M, El-Banayosy A, et al. Mechanical circulatory support for advanced heart failure: effect of patient selection on outcome. Circulation. 2001;103:231–237
  14. Holman WL, Kormos RL, Naftel DC, et al. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study. J Heart Lung Transplant. 2009;28:44–50
  15. Holman WL, Pae WE, Teutenberg JJ, et al. INTERMACS: interval analysis of registry data. J Am Coll Surg. 2009;208:755–761discussion 61–2
  16. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation. 2007;116:497–505
  17. Rao V, Oz MC, Flannery MA, Catanese KA, Argenziano M, Naka Y. Revised screening scale to predict survival after insertion of a left ventricular assist device. J Thorac Cardiovasc Surg. 2003;125:855–862
  18. Dang NC, Topkara VK, Mercando M, et al. Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant. 2006;25:1–6
  19. Kavarana MN, Pessin-Minsley MS, Urtecho J, et al. Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg. 2002;73:745–750
  20. Sandner SE, Zimpfer D, Zrunek P, et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg. 2009;87:1072–1078
  21. McBride LR, Naunheim KS, Fiore AC, et al. Risk analysis in patients bridged to transplantation. Ann Thorac Surg. 2001;71:1839–1844
  22. Topkara VK, Dang NC, Barili F, et al. Predictors and outcomes of continuous veno-venous hemodialysis use after implantation of a left ventricular assist device. J Heart Lung Transplant. 2006;25:404–408
  23. Genovese EA, Dew MA, Teuteberg JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg. 2009;88:1162–1170
  24. Esmore D, Kaye D, Spratt P, et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant. 2008;27:579–588
  25. Sharples LD, Cafferty F, Demitis N, et al. Evaluation of the clinical effectiveness of the Ventricular Assist Device Program in the United Kingdom (EVAD UK). J Heart Lung Transplant. 2007;26:9–15
  26. Argenziano M, Catanese KA, Moazami N, et al. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices. J Heart Lung Transplant. 1997;16:822–831
  27. Simon D, Fischer S, Grossman A, et al. Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis. 2005;40:1108–1115
  28. Schulman AR, Martens TP, Russo MJ, et al. Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant. 2009;28:237–242
  29. Bhama JK, Rayappa S, Zaldonis D, et al. Impact of abdominal complications on outcome after mechanical circulatory support. Ann Thorac Surg. 2010;89:522–528discussion 8–9
  30. Interagency Registry for Mechanically Assisted Circulatory Support. http://www.intermacs.org/2009;Accessed: Dec 1
  31. Zahr F, Ootaki Y, Starling RC, et al. Preoperative risk factors for mortality after biventricular assist device implantation. J Card Fail. 2008;14:844–849
  32. Kanter KR, Swartz MT, Pennington DG, et al. Renal failure in patients with ventricular assist devices. ASAIO Trans. 1987;33:426–428
  33. Kaltenmaier B, Pommer W, Kaufmann F, Hennig E, Molzahn M, Hetzer R. Outcome of patients with ventricular assist devices and acute renal failure requiring renal replacement therapy. ASAIO J. 2000;46:330–333
  34. Bhama JK, Kormos RL, Toyoda Y, Teuteberg JJ, McCurry KR, Siegenthaler MP. Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support. J Heart Lung Transplant. 2009;28:971–976
  35. Pagani FD, Miller LW, Russell SD, et al. Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. J Am Coll Cardiol. 2009;54:312–321
  36. McKenna DH, Eastlund T, Segall M, Noreen HJ, Park S. HLA alloimmunization in patients requiring ventricular assist device support. J Heart Lung Transplant. 2002;21:1218–1224
  37. Sihler KC, Napolitano LM. Complications of massive transfusion. Chest. 2010;137:209–220
  38. Asadollahi K, Beeching NJ, Gill GV. Leukocytosis as a predictor for non-infective mortality and morbidity. QJM. 2010;103:285–292
  39. Forman DE, Butler J, Wang Y, et al. Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol. 2004;43:61–67
  40. Hillege HL, Girbes AR, de Kam PJ, et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation. 2000;102:203–210
  41. Russell SD, Rogers JG, Milano CA, et al. Renal and hepatic function improve in advanced heart failure patients during continuous-flow support with the HeartMate II left ventricular assist device. Circulation. 2009;120:2352–2357
  42. Sandner SE, Zimpfer D, Zrunek P, et al. Renal function after implantation of continuous versus pulsatile flow left ventricular assist devices. J Heart Lung Transplant. 2008;27:469–473
  43. Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices. J Heart Lung Transplant. 2007;26:815–818
  44. James KB, McCarthy PM, Jaalouk S, et al. Plasma volume and its regulatory factors in congestive heart failure after implantation of long-term left ventricular assist devices. Circulation. 1996;93:1515–1519
  45. Gaudino M, Luciani N, Giungi S, et al. Different profiles of patients who require dialysis after cardiac surgery. Ann Thorac Surg. 2005;79:825–829author reply 9–30

PII: S1053-2498(10)00271-8

doi: 10.1016/j.healun.2010.04.014

The Journal of Heart and Lung Transplantation
Volume 29, Issue 9 , Pages 981-988 , September 2010

Article Tools

* Image Usage & Resolution